Wednesday, October 7, 2026 • 9:10 PM EDT
Good morning, traders. Spencer here with your Morning Market Report. We've got an interesting setup heading into Thursday, October 8, but I'm not seeing the kind of broad strength that makes me want to get aggressive right out of the gate. Wednesday's latest readings showed the S&P 500 ETF, SPY, down 0.23%, while the Nasdaq 100 ETF, QQQ, slipped 0.23%. The Dow ETF, DIA, fell a steeper 0.69%. All three recovered somewhat from their session opens, but none managed to reclaim the previous close. That's an important distinction: we saw some intraday improvement, not a confirmed bullish turnaround.
The bigger concern is what's happening beneath the surface. Small caps took a harder hit, with IWM dropping 1.30%. Industrials fell 2.16%, materials lost 1.54%, and real estate declined 1.31%. Meanwhile, healthcare gained 1.01%, making it the strongest sector in our data. Technology finished down 0.39%, although it improved from its opening level. That tells me there's some selective resilience, but participation isn't broad enough to justify chasing every green candle. Energy also struggled, with XLE losing 0.55% and finishing below its opening price.
On the news front, quantum computing deserves attention. IonQ announced advancement to Stage C of DARPA's quantum benchmarking initiative under an agreement potentially worth up to $300 million. IBM was also selected for Stage C. Separately, Rivian announced a $1 billion, 10-year loan from Volkswagen Group at a fixed 6.03% interest rate, secured by Rivian's 50% interest in their existing joint venture. Applied Digital and Levi Strauss also held earnings calls Wednesday. These are legitimate company-specific developments, but we still need price action to determine whether traders are responding positively.
For Thursday, my approach is patience. Wednesday's sector divergence suggests opportunities may exist in individual names, but the broader market hasn't earned an aggressive bullish stance. I want to see buyers establish control after the opening bell, particularly in technology and healthcare. If that confirmation doesn't arrive, there's no reason to force a trade.
☀️ Morning Snapshot
- S&P 500 (SPY): $777.30, down 0.23% versus its previous close.
- Nasdaq 100 (QQQ): $757.84, down 0.23%, but up 0.54% from Wednesday's open.
- Dow (DIA): $511.00, down 0.69%.
- Small caps (IWM): $277.67, down 1.30%, signaling weaker participation.
- Sector leader: Healthcare gained 1.01%; industrials lagged at -2.16%.
⌖ On My Radar
- XLV — Healthcare: Wednesday's strongest sector. Watching whether relative strength continues.
- IONQ: DARPA Stage C advancement and an agreement potentially worth $300 million provide a company-specific catalyst.
- IBM: Also selected for DARPA's Stage C quantum benchmarking initiative.
- RIVN: Volkswagen-backed financing announcement could attract attention. Price confirmation is essential.
- QQQ: Wednesday's recovery from its opening level makes technology-related strength worth monitoring.
📈 What I Want to See Next
- SPY and QQQ: Can they reclaim their previous closing levels and hold above them?
- Healthcare: Does XLV continue outperforming, or does Wednesday's leadership fade?
- Small caps: IWM needs to stabilize before I'm comfortable calling participation healthier.
- Headline names: Watch whether IONQ, IBM, and RIVN attract sustained buying rather than short-lived enthusiasm.
🎯 Spencer's Call
🟡 BE SELECTIVE
There are interesting developments worth watching, but Wednesday's weak breadth argues against jumping into everything that moves. Focus on clean setups, wait for confirmation, and remember that cash is a perfectly respectable position.
That's your morning game plan. Stay disciplined, protect your capital, and let the market show its hand before you show yours. Spencer out.